Finland· FI-REL-REL4177
Tomudex
A raltitrexed product containing raltitrexed, registered in Finland by AstraZeneca Oy. The same ATC class is registered in 7 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Raltitrexed is registered in 7 of 19 countries.
Countries holding a registration under ATC L01BA03 (raltitrexed), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 5 of them publish a price we can compare per daily dose
Raltitrexed · ATC L01BA03
7 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Franceprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Raltitrexed
- Manufacturer
- AstraZeneca Oy
- Country
- Finland (FI)
- ATC code
- L01BA03
- ATC class
- Raltitrexed
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Raltitrexed in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTomudex 2 mgHospira Benelux
- SpainTOMUDEX 2 MG POLVO PARA SOLUCION PARA PERFUSIONHospira Invicta S.A.
- United KingdomTomudex 2mg powder for solution for infusion vialsPfizer Ltd
- CanadaTOMUDEXPFIZER CANADA ULC
- SwitzerlandTomudex 2 mg, Pulver zur Herstellung einer InfusionslösungPfizer AG
- FranceTOMUDEX 2 mg, poudre pour solution pour perfusionPFIZER HOLDING FRANCE
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Tomudex
- Belgium · Tomudex
- Spain · Tomudex
- France · Tomudex
- United Kingdom (Northern Ireland) · Tomudex
- Hungary · Tomudex
- Italy · Tomudex
- Luxembourg · Tomudex
- Malta · Tomudex
- Portugal · Tomudex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d89daee0-509d-4bf2-9983-d459158cbea2 GET /v1/drugs/d89daee0-509d-4bf2-9983-d459158cbea2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "infuusiokuiva-aine, liuosta varten",
"route": null,
"ddd_unit": null,
"strength": "2 mg",
"atc_label": "raltitreksedi",
"ma_number": "12100",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL4177",
"authorised_at": "1997-01-13"
}See everything about raltitrexed.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.